for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Outlook Therapeutics Inc

OTLK.O

Latest Trade

1.33USD

Change

0.03(+2.31%)

Volume

75,155

Today's Range

1.28

 - 

1.36

52 Week Range

0.85

 - 

10.96

As of on the NASDAQ ∙ Minimum 15 minute delay

Officers & DirectorsAs of

NameAgePositionAppointed
Ralph H. Thurman
Executive Chairman of the Board
--Executive Chairman of the Board2018
Lawrence A. Kenyon
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
53President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director2018
Terry Dagnon
Chief Operating Officer
57Chief Operating Officer2018
Scott A. Gangloff
Senior Vice President - Development and Manufacturing
43Senior Vice President - Development and Manufacturing2015
Jennifer Kissner
Senior Vice President, Clinical Development
--Senior Vice President, Clinical Development2019
Stephen J. McAndrew
Senior Vice President - Business Strategy & Development
63Senior Vice President - Business Strategy & Development2014
Kogan Bao
Vice President - Analytical Sciences
47Vice President - Analytical Sciences2016
Elizabeth A. Yamashita
Vice President - Regulatory Affairs
56Vice President - Regulatory Affairs2015
Jeff Evanson
Chief Commercial Officer
50Chief Commercial Officer2018
Yezan Munther Haddadin
Director
--Director2018
Kurt J. Hilzinger
Independent Director
58Independent Director2015
Faisal Ghiath Sukhtian
Independent Director
33Independent Director2017
Joe Thomas
Independent Director
60Independent Director2017

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up